Delivery Order SPE2DB24D1034-SPE2DB25FWCT1

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The $4,008.89 firm fixed-price contract has an ultimate completion date of August 8, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,387.28 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, with ID SPE2DB20D3505 and SPE2DB25FU0S9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,860.96 delivery order contract is for the supply of 500 capsules of the drug Ramipril 5 mg. The contract has a firm fixed price and an ultimate completion date of February 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,779.78 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a medication used to treat high blood pressure and heart failure. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.77, is for the delivery of 4,558,957,998 units of Ramipril 10 mg capsules, which are a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of November 2, 2022. It is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.40 firm fixed-price delivery order is for the supply of 4,558,265,410 capsules of 10 mg Ramipril, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 30, 2022 and was awarded on August 29, 2022. This award is associated with a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $3,896.40 firm fixed price contract has an ultimate completion date of August 22, 2024. As this is a delivery order, it is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 for the supply of a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,129.43 firm fixed-price delivery order is for the supply of 500 capsules of 10 mg Ramipril, a medication used to treat high blood pressure and heart failure. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The contract, which has a ceiling value of $2,650.03, is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,007.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWCT1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.29 firm fixed-price delivery order is for the supply of 100 capsules of the medication Ramipril 10 mg. The contract has an ultimate completion date of May 8, 2025 and was awarded on May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract award does not have a set-aside designation, indicating open competition.

Generated 8/6/25, 9:58 AM